ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Stock Short Interest Climbs 264.0%

Posted by Lauren Steadman on Sep 28th, 2026

ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 124,227 shares, an increase of 264.0% from the August 31st total of 34,125 shares. Based on an average trading volume of 63,432 shares, the short-interest ratio is currently 2.0 days. Currently, 0.1% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research note on Monday, July 6th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

View Our Latest Stock Analysis on ALPS

Institutional Trading of ALPS Group Inc Ordinary Share

A hedge fund recently raised its stake in ALPS Group Inc Ordinary Share stock. SkyView Investment Advisors LLC lifted its stake in shares of ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Free Report) by 1,000.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 110,000 shares of the company’s stock after buying an additional 100,000 shares during the period. SkyView Investment Advisors LLC owned about 0.07% of ALPS Group Inc Ordinary Share worth $64,000 as of its most recent SEC filing. 27.90% of the stock is owned by hedge funds and other institutional investors.

ALPS Group Inc Ordinary Share Stock Performance

ALPS opened at $0.40 on Monday. The firm has a market cap of $65.89 million, a P/E ratio of 1.20 and a beta of -0.10. The firm has a 50 day moving average of $0.39. ALPS Group Inc Ordinary Share has a 1-year low of $0.23 and a 1-year high of $15.00.

About ALPS Group Inc Ordinary Share

(Get Free Report)

ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.